Edward Owens Net Worth & Insider Trades
Edward Owens - Director, Ironwood Pharmaceuticals Inc
What is Edward Owens's Net Worth?
The current estimated net worth of Ironwood Pharmaceuticals Inc's Director, Edward Owens, is estimated to be about $2.48M . Edward Owens owns about 258,954 units of Ironwood Pharmaceuticals Inc common stock. In the last 8 years at Ironwood Pharmaceuticals Inc, Edward Owens has sold an estimated value of $0 worth.
What is Edward Owens's Past Insider Trading?
Edward Owens's largest purchase order was 12,000 units , worth over $110.37K on February 26, 2021. In total, Edward Owens has made about 14 transactions over 8 years of their time at Ironwood Pharmaceuticals Inc. Edward Owens usually trades in June, with the busiest year in 2021. The most recent transaction was a purchase order of 3,000 units , worth over $26.7K on March 2, 2021.
Edward Owens
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Edward Owens's' Mailing Address?
- Mailing address is C/o Ironwood Pharmaceuticals, Inc. 100 Summer Street, Suite 2300 Boston MA 02110 MA
Ironwood Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Mark Mallon* | 2020 | $801,173 | - | $5,423,731 | - | $585,169 | $11,040 | $6,821,113 |
| Mark Mallon* | 2019 | $750,000 | $880,000 | $3,692,810 | $3,804,331 | $797,063 | $144,596 | $10,068,800 |
| Mark Mallon* | 2018 | - | - | - | - | - | - | - |
| Gina Consylman | 2020 | $512,751 | - | $1,676,402 | - | $264,652 | $11,040 | $2,464,845 |
| Gina Consylman | 2019 | $480,000 | $250,000 | $1,467,731 | $888,546 | $358,800 | $8,502 | $3,453,579 |
| Gina Consylman | 2018 | $415,000 | - | $782,385 | $501,764 | $207,500 | $8,040 | $1,914,688 |
| Thomas McCourt* | 2020 | $576,120 | - | $2,465,327 | - | $357,409 | $11,040 | $3,409,896 |
| Thomas McCourt* | 2019 | $511,250 | - | $1,760,143 | $2,370,159 | $454,272 | $8,502 | $5,104,327 |
| Thomas McCourt* | 2018 | $465,000 | - | $549,641 | $869,479 | $232,500 | $34,002 | $2,150,622 |
| Jason Rickard | 2020 | $473,314 | - | $1,479,191 | - | $258,338 | $11,040 | $2,221,883 |
| Jason Rickard | 2019 | - | - | - | - | - | - | - |
| Jason Rickard | 2018 | - | - | - | - | - | - | - |
| Michael Shetzline, M.D., Ph.D. | 2020 | $464,681 | $100,000 | $1,121,001 | - | $194,558 | $11,040 | $1,891,310 |
| Michael Shetzline, M.D., Ph.D. | 2019 | - | - | - | - | - | - | - |
| Michael Shetzline, M.D., Ph.D. | 2018 | - | - | - | - | - | - | - |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1446847/000104746921001006/a2243150zdef14a.htm
What are Ironwood Pharmaceuticals Inc's Past Insider Trades?
Ironwood Pharmaceuticals Inc's most recent insider trade came on August 15, 2022 by Mark Currie who sold 70,000 units worth $824.6K . In the last 12 years, insiders at Ironwood Pharmaceuticals Inc have sold an estimated value of $113.48M and bought an estimated value of $40.81M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Mark Currie, Director, Thomas McCourt, Chief Executive Officer, and Bryan E Roberts, Director .
IRONWOOD PHARMACEUTICALS INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||